Your browser is no longer supported. Please, upgrade your browser.
DVA DaVita Inc. daily Stock Chart
DaVita Inc.
IndexS&P 500 P/E16.64 EPS (ttm)3.29 Insider Own0.40% Shs Outstand161.80M Perf Week-5.40%
Market Cap8.85B Forward P/E10.30 EPS next Y5.31 Insider Trans0.00% Shs Float156.54M Perf Month-7.18%
Income547.50M PEG0.87 EPS next Q1.22 Inst Own97.30% Short Float5.80% Perf Quarter15.01%
Sales11.25B P/S0.79 EPS this Y4.20% Inst Trans0.74% Short Ratio3.17 Perf Half Y-6.08%
Book/sh24.34 P/B2.25 EPS next Y12.86% ROA0.70% Target Price65.09 Perf Year-24.08%
Cash/sh22.13 P/C2.47 EPS next 5Y19.16% ROE3.50% 52W Range43.40 - 79.11 Perf YTD6.30%
Dividend- P/FCF7.87 EPS past 5Y4.40% ROI9.20% 52W High-30.86% Beta1.56
Dividend %- Quick Ratio1.10 Sales past 5Y-0.60% Gross Margin28.80% 52W Low26.04% ATR1.32
Employees77700 Current Ratio1.10 Sales Q/Q-1.50% Oper. Margin13.10% RSI (14)35.53 Volatility2.31% 2.17%
OptionableYes Debt/Eq2.21 EPS Q/Q2.60% Profit Margin1.20% Rel Volume1.29 Prev Close55.96
ShortableYes LT Debt/Eq1.33 EarningsAug 01 AMC Payout0.00% Avg Volume2.86M Price54.70
Recom2.20 SMA20-6.77% SMA50-3.24% SMA200-1.76% Volume3,688,209 Change-2.25%
Jul-26-19Downgrade Robert W. Baird Outperform → Neutral $70 → $65
Jan-08-19Upgrade UBS Sell → Neutral
Jan-03-19Initiated Deutsche Bank Buy $60
Dec-14-18Initiated Barclays Overweight
Nov-28-18Upgrade Raymond James Mkt Perform → Outperform
Nov-16-18Initiated UBS Sell $64
Nov-08-18Downgrade Raymond James Strong Buy → Mkt Perform
Sep-13-18Upgrade JP Morgan Underweight → Neutral
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Robert W. Baird Neutral → Outperform $63 → $82
Dec-11-17Upgrade Citigroup Neutral → Buy
Dec-07-17Upgrade Raymond James Outperform → Strong Buy
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $64 → $60
Oct-09-17Downgrade JP Morgan Neutral → Underweight
Jun-26-17Downgrade Jefferies Buy → Hold
Dec-13-16Downgrade Robert W. Baird Outperform → Neutral $68 → $69
Sep-20-16Upgrade Raymond James Mkt Perform → Outperform
Sep-06-16Initiated Citigroup Neutral
Sep-06-16Downgrade BofA/Merrill Buy → Neutral
Feb-16-16Reiterated RBC Capital Mkts Sector Perform $80 → $71
Aug-22-19 04:24PM  Andreas Halvorsen Keeps Buying Centene, DaVita
06:30AM  Davita Announces Final Results Of Self-Tender Offer PR Newswire
Aug-21-19 09:12AM  DaVita buys back $1.2 billion worth of stock from shareholders American City Business Journals
Aug-20-19 11:55AM  RingCentral, Tapestry,, DaVita and Aercap highlighted as Zacks Bull and Bear of the Day Zacks
07:45AM  Here's Why You Should Invest in DaVita (DVA) Stock For Now Zacks
Aug-19-19 05:21PM  Wall Street Rallies Monday
09:35AM  Is DaVita (DVA) a Profitable Stock for Value Investors Now? Zacks
06:55AM  5 Price-to-Book Value Picks to Improve Portfolio Returns Zacks
06:30AM  DaVita Announces Preliminary Results Of Self-Tender Offer PR Newswire
Aug-16-19 04:09PM  Main Wall Street Indexes Extend Gains Friday
08:53AM  Outlook for Outpatient and Home Healthcare Industry Looks Bright Zacks
07:16AM  SSM Health partners with Denver firm to offer new primary care option American City Business Journals
Aug-14-19 08:51AM  The Zacks Analyst Blog Highlights: Alamos Gold, Chemed, Safehold, Franco-Nevada and DaVita Zacks
Aug-13-19 09:30AM  DVA or CHE: Which Is the Better Value Stock Right Now? Zacks
09:26AM  5 Safe Picks Amid Yield Inversion and Geopolitical Concerns Zacks
09:15AM  Better Than Last Monday, but Still Down Over 1% Zacks
Aug-12-19 11:46AM  DaVita Announces New Senior Secured Credit Agreement PR Newswire
Aug-08-19 11:55AM featured highlights include: DaVita, Kraton, ADT, Universal Forest Products and International Game Zacks
10:20AM  Why DaVita HealthCare (DVA) Might be Well Poised for a Surge Zacks
Aug-07-19 10:45AM  The Zacks Analyst Blog Highlights: Industrial Logistics, Medpace, Unitil, DaVita and Telephone and Data Zacks
06:50AM  5 Value Picks Boasting Strikingly Low EV/EBITDA Ratios Zacks
03:34AM  Edited Transcript of DVA earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-06-19 09:20AM  Relative Price Strength Make These 5 Stocks Worth a Look Now Zacks
09:19AM  5 Stocks to Buy on a Possible Second Rate Cut in September Zacks
Aug-05-19 10:25AM  Stock Market News For Aug 5, 2019 Zacks
Aug-02-19 10:22AM  Stock Market News for Aug 02, 2019 Zacks
09:32AM  DaVita sees growth slowdown ahead of federal changes to kidney care American City Business Journals
08:22AM  DaVita (DVA) Earnings Beat, Revenues Miss Estimates in Q2 Zacks
03:24AM  DaVita (DVA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-01-19 05:15PM  DaVita HealthCare (DVA) Q2 Earnings Top Estimates Zacks
04:01PM  DaVita Inc. 2nd Quarter 2019 Results PR Newswire
07:56AM  6 Promising Price-to-Book Value Stocks to Buy in August Zacks
07:36AM  Earnings Preview For DaVita Benzinga
Jul-31-19 09:05AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings? Zacks
Jul-30-19 12:28PM  Innovation in Home Care Delivery Improves the Quality of Life for More Kidney Patients PR Newswire
09:15AM  All Mixed Up to Start Fed Week Zacks
09:14AM  At US$59.66, Is It Time To Put DaVita Inc. (NYSE:DVA) On Your Watch List? Simply Wall St.
08:56AM  Cigna (CI) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-29-19 11:14AM  Is a Beat in the Cards for Humana's (HUM) Earnings in Q2? Zacks
10:04AM  What's in the Cards for DaVita (DVA) This Earnings Season? Zacks
09:25AM  DaVita talks plans for home dialysis growth in wake of federal order American City Business Journals
Jul-26-19 01:49PM  Reducing Blind Spots
10:11AM  Top Ranked Momentum Stocks to Buy for July 26th Zacks
Jul-25-19 10:33AM  DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy? Zacks
09:30AM  DVA vs. CHE: Which Stock Is the Better Value Option? Zacks
Jul-23-19 11:54AM  US Stocks Climb Monday
09:39AM  Stock Market News For Jul 23, 2019 Zacks
08:48AM  DaVita (DVA) Announces Preliminary Q2 Results, View Upbeat Zacks
Jul-22-19 01:39PM  DaVita News: DVA Stock Soars on Upbeat Guidance InvestorPlace
01:02PM  DaVita Inc. -- Moody's assigns Ba1 rating to DaVita's new senior secured debt, affirms Ba2 CFR Moody's
11:30AM  DaVita Jumps After Dialysis-Clinic Operator Boosts 2019 Forecast Bloomberg
09:37AM  DaVita Stock Jumps Because Its Next Earnings Report Should Be a Good One
07:40AM  DaVita's stock rallies after profit outlook raised MarketWatch
06:30AM  DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share PR Newswire
06:02AM  DaVita Soars on Upbeat Earnings Guidance
05:00AM  DaVita Inc. Announces Preliminary Second Quarter 2019 Results and Updated Guidance for Fiscal Year 2019 PR Newswire
04:59AM  DaVita Inc. Schedules 2nd Quarter 2019 Investor Conference Call PR Newswire
Jul-18-19 08:51AM  UnitedHealth (UNH) Beats on Q2 Earnings, Guides Up for 2019 Zacks
Jul-17-19 06:52PM  Industry Knowledge: How Much Is Enough?
04:00PM  CVS Health Tests Home Dialysis System; DaVita, Fresenius Hit Investor's Business Daily
08:00AM  CVS enters home dialysis care with clinical trial of new system Reuters
Jul-16-19 07:14AM  UnitedHealth (UNH) to Report Q2 Earnings: What's in Store? Zacks
Jul-14-19 12:12PM  Blind Spots in Investing
Jul-12-19 12:08PM  Why Fresenius Is the Initial Winner From Trump's Kidney Disease Overhaul
10:28AM  The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS Zacks
07:00AM  Home Dialysis to Benefit These Undervalued Providers Morningstar
Jul-11-19 05:06PM  Dow Jones Passes 27,000 for the 1st Time
01:53PM  Humana, CVS, and DaVita Stocks Could Benefit From Trump Overhaul of Kidney Care, Analysts Say
09:20AM  Trump's Order on Kidney Care Lifts These Dialysis Stocks Zacks
08:50AM  3 Big Stock Charts for Thursday: Davita, Honeywell and Advanced Micro Devices InvestorPlace
Jul-10-19 05:53PM  US Market Indexes Higher on Wednesday
05:32PM  Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others Zacks
04:58PM  Trump Calls for Overhaul of Costly Kidney Dialysis Program Bloomberg
03:01PM  DaVita Statement on Advancing American Kidney Health PR Newswire
02:13PM  How DaVita could be impacted by Trump's action on kidney health American City Business Journals
02:03PM  Trump celebrates dismissal of foreign-payments case as he directs kidney-care overhaul MarketWatch
01:26PM  DaVita, American Renal stocks bounce after President Trump signs executive order on kidney disease MarketWatch
09:58AM  UPDATE 3-Trump administration pushes U.S. at-home kidney care, transplant availability Reuters
05:01AM  Trump Targets Dialysis, Kidney Transplants in Care Overhaul Bloomberg
Jul-09-19 04:34PM  Why DaVita, AquaVenture Holdings, and Liberty Oilfield Services Slumped Today Motley Fool -5.33%
12:37PM  Trumps Next Phase on Health Care: Everywhere and Nowhere Bloomberg
10:46AM  Bears Are Blitzing This Stock Before Trump Announcement Schaeffer's Investment Research
07:12AM  DaVita Lower as HHS Plans to Emphasize At-Home Dialysis Treatment
Jul-04-19 02:25PM  Calculating The Fair Value Of DaVita Inc. (NYSE:DVA) Simply Wall St.
Jul-01-19 06:00AM  Healthcare: Drugmakers and Providers Look Attractive Morningstar
Jun-26-19 06:12PM  UnitedHealth (UNH) Closes DaVita Unit Buy, Expands OptumCare Zacks
Jun-21-19 09:44AM  UnitedHealth Dip on Report It May Buy Payments Group Equian for $3.2 Billion
Jun-20-19 10:26AM  UnitedHealth Investors Cheer Long-Delayed Approval to Acquire Doctors Network
09:02AM  DaVita Divests DMG to Optum, Boosts Kidney Care Services Zacks
Jun-19-19 04:55PM  'From the get-go we're on the case': Why Colorado's AG made an unprecedented antitrust move American City Business Journals
04:55PM  Optum Completes Acquisition of DaVita Medical Group from DaVita Business Wire
04:44PM  U.S. trade regulator approves United Health, DaVita deal with condition MarketWatch
04:26PM  U.S. FTC approves UnitedHealth's proposed purchase of DaVita unit Reuters
Jun-10-19 03:30PM  Heres What Hedge Funds Think About DaVita Inc (DVA) Insider Monkey
Jun-07-19 05:11PM  U.S. Renal Care, Inc (New) -- Moody's assigns a Caa2 rating to the senior unsecured notes of US Renal Care, Inc. (NEW) Moody's
Jun-06-19 04:12PM  DaVita's employees played a strong role in creating its support for the LGBTQ community American City Business Journals
09:31AM  Why Is DaVita HealthCare (DVA) Down 9.9% Since Last Earnings Report? Zacks
Jun-03-19 12:42PM  Here's What DaVita Inc.'s (NYSE:DVA) P/E Ratio Is Telling Us Simply Wall St.
May-30-19 12:28PM  U.S. RENAL CARE, INC. (NEW) -- Moody's assigns a B3 CFR to US Renal Care, Inc. (NEW); outlook stable Moody's
May-29-19 01:56PM  Final trades: Marsh & McLennan, Crown Castle, Union Pacific, DaVita, & biotech CNBC Videos -5.39%
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2018, it provided dialysis and administrative services in the United States through a network of 2,664 outpatient dialysis centers serving approximately 202,700 patients; and operated 241 outpatient dialysis centers located in 9 countries outside of the United States serving approximately 25,000 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.